Literature DB >> 10644059

Anticipating prostatic volume changes due to prostate brachytherapy.

K R Badiozamani1, K Wallner, S Sutlief, W Ellis, J Blasko, K Russell.   

Abstract

The purpose of the study was to determine which clinical parameters might predict individual prostate volume changes from prostate brachytherapy. Fifty consecutive, unselected patients treated at the University of Washington by I-125 or Pd-103 implantation for prostatic carcinoma in 1998 were analyzed. The prostate contours on preimplant transrectal ultrasound (TRUS) images were digitized and the prostate volumes calculated. Postimplant axial CT images of the prostate was obtained at 0.5 cm intervals with patients in the supine position the morning after the implant. The postimplant prostate volume increased by an average factor of 1.7 (+/-0.34) compared with the preimplant volume, the size increase being primarily in the anterior-posterior dimension. The absolute volume change was similar in patients with small vs. large preimplant prostate volume (r = -0.39), but the proportional change was less in patients with a larger prostate volume (r = -0.71). Because patients with a small preimplant prostate had proportionately greater volume increase, their postimplant target coverage was generally less. No single parameter, including preimplant prostate volume, preimplant hormonal deprivation, or supplemental external beam radiation therapy (EBRT) can accurately predict the degree of swelling. The precise significance of and practical solution to implant-related prostate volume changes remains to be determined.

Entities:  

Mesh:

Year:  1999        PMID: 10644059     DOI: 10.1002/(SICI)1520-6823(1999)7:6<360::AID-ROI6>3.0.CO;2-D

Source DB:  PubMed          Journal:  Radiat Oncol Investig        ISSN: 1065-7541


  5 in total

1.  Preimplant factors affecting postimplant CT-determined prostate volume and the CT/TRUS volume ratio after transperineal interstitial prostate brachytherapy with 125I free seeds.

Authors:  Akitomo Sugawara; Jun Nakashima; Etsuo Kunieda; Hirohiko Nagata; Hirotaka Asakura; Mototsugu Oya; Naoyuki Shigematsu
Journal:  Radiat Oncol       Date:  2010-09-28       Impact factor: 3.481

2.  AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.

Authors:  Ravinder Nath; William S Bice; Wayne M Butler; Zhe Chen; Ali S Meigooni; Vrinda Narayana; Mark J Rivard; Yan Yu
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

3.  The impact of prostate edema on cell survival and tumor control after permanent interstitial brachytherapy for early stage prostate cancers.

Authors:  Zhe Jay Chen; Kenneth Roberts; Roy Decker; Pradip Pathare; Sara Rockwell; Ravinder Nath
Journal:  Phys Med Biol       Date:  2011-07-19       Impact factor: 3.609

4.  Evaluation of the effect of prostate volume change on tumor control probability in LDR brachytherapy.

Authors:  Courtney Knaup; Panayiotis Mavroidis; Sotirios Stathakis; Mark Smith; Gregory Swanson; Niko Papanikolaou
Journal:  J Contemp Brachytherapy       Date:  2011-09-30

5.  Case series analysis of post-brachytherapy prostate edema and its relevance to post-implant dosimetry. Post-implant prostate edema and dosimetry.

Authors:  Ajay Tejwani; Eva Bieniek; Lindsay Puckett; Amir Lavaf; Adel Guirguis; Aaron Bennish; Hani Ashamalla
Journal:  J Contemp Brachytherapy       Date:  2012-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.